ImmuneRegen BioSciences Announces Material Transfer Agreement with HemoGenix®
News Jan 29, 2008
ImmuneRegen BioSciences has announces a Materials Transfer Agreement (MTA) with HemoGenix®, a Contract Research Service Laboratory that provides a 21st-century approach to developing stem cell assays for the biotechnology and pharmaceutical industry.
ImmuneRegen says that its high-throughput technology imparts standardization of stem cell assays, making HemoGenix a valuable collaborator. As part of the agreement, ImmuneRegen will ship its therapeutic candidate Homspera® for testing using a number of proprietary tools developed and validated by HemoGenix.
HemoGenix will explore the potential of Homspera to stimulate hematopoietic stem cell proliferation and differentiation using their instrument-based ATP bioluminescence technology.
By combining a traditional approach for examining stem cell differentiation with a fluorescent tool for measuring proliferation, HemoGenix provides a way to standardize and validate the widely-used stem cell colony-forming cell differentiation assay.
Earlier studies performed by ImmuneRegen have shown the ability of Homspera to modify the number of leukocytes circulating in the blood of animals exposed to lethal and sub lethal doses of ionizing radiation.
Additional studies are underway to better understand this activity and explore potential therapeutic capabilities in fields as diverse as cancer, immunological disorders, wound healing, regenerative medicine and radioprotection.
The agreement with HemoGenix highlights ImmuneRegen’s continued progress in its research and development efforts. ImmuneRegen has recently announced research initiatives with a number of major partners in the biotechnology industry, and has sourced $3 million of capital to continue Homspera product development.
Unraveling How Mesenchymal Stem Cells From Gum Tissue Accelerate Wound HealingNews
To assist with wound healing, mesenchymal stem cells from the gum tissue secrete extracellular vesicles that contain the anti-inflammatory signaling molecule IL-1RA.READ MORE
Mending Broken Hearts with Cardiomyocyte MoldsNews
A team of researchers at Michigan Technological University in collaboration with Harvard Medical School, shows how cardiomyocytes grown in a heart-like environment mature more quickly, have improved functionality and are less likely to be rejected by patients’ bodies.READ MORE
Engineered Cartilage Template to Heal Broken BonesNews
A team of UConn Health researchers has designed a novel, hybrid hydrogel system to help address some of the challenges in repairing bone in the event of injury.READ MORE
Comments | 0 ADD COMMENT
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018